SEC Form 4 · accession 0001209191-16-148950
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
K Peony Yu
Officer — Chief Medical Officer
Period of report
Nov 8, 2016
Accepted (ET)
Nov 8, 2016 · 8:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 8, 2016 | M | 2,000 | $3.50 | A | 208,502 | D | |
| Common Stock | Nov 8, 2016 | M | 2,700 | $5.95 | A | 211,202 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $3.50 | Nov 8, 2016 | M | 2,000 | D | — | Jun 7, 2021 | Common Stock | 2,000 | 0 | D |
| Stock Option (Right to Buy)F1 | $5.95 | Nov 8, 2016 | M | 2,700 | D | — | Jun 27, 2022 | Common Stock | 2,700 | 1,800 | D |
Explanation of responses
- F1Fully vested.